Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.63B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.18B |
| 4 |
Amazon
AMZN
|
+$978M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$769M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$509M |
| 2 |
Chevron
CVX
|
+$405M |
| 3 |
T-Mobile US
TMUS
|
+$339M |
| 4 |
lululemon athletica
LULU
|
+$302M |
| 5 |
ACC
American Campus Communities, Inc.
ACC
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.69% |
| 2 | Financials | 14.38% |
| 3 | Healthcare | 14.2% |
| 4 | Consumer Discretionary | 10.56% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Heron Therapeutics
HRTX
$94.1M
| $2.48M | ﹤0.01% |
887,122
+63,800
| +8% | +$256K |
|
1877
Kodiak Sciences
KOD
$2.66B
| $2.45M | ﹤0.01% |
321,116
-196,100
| -38% | -$1.38M |
|
1878
ArcBest
ARCB
$3.17B
| $2.44M | ﹤0.01% |
+34,725
| New | +$2.55M |
|
1879
Inovio Pharmaceuticals
INO
$54M
| $2.43M | ﹤0.01% |
116,900
| – | – |
|
1880
Alignment Healthcare
ALHC
$3.85B
| $2.42M | ﹤0.01% |
212,039
| – | – |
|
|
NXRT
1881
NexPoint Residential Trust
NXRT
$677M
| $2.41M | ﹤0.01% |
+38,600
| New | +$2.94M |
|
1882
The RealReal
REAL
$1.44B
| $2.35M | ﹤0.01% |
943,700
+227,300
| +32% | +$1.01M |
|
1883
Hackett Group
HCKT
$269M
| $2.33M | ﹤0.01% |
122,900
+47,000
| +62% | +$1.01M |
|
1884
Teva Pharmaceuticals
TEVA
$41.2B
| $2.33M | ﹤0.01% |
+310,000
| New | +$2.7M |
|
|
BNT
1885
Brookfield Wealth Solutions
BNT
$11.7B
| $2.3M | ﹤0.01% |
77,496
-61,253
| -44% | -$2.04M |
|
1886
Stride
LRN
$3.53B
| $2.26M | ﹤0.01% |
55,400
-271,100
| -83% | -$10M |
|
1887
Travere Therapeutics
TVTX
$5.33B
| $2.23M | ﹤0.01% |
+91,900
| New | +$2.31M |
|
|
PWSC
1888
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $2.22M | ﹤0.01% |
184,346
| – | – |
|
1889
Altimmune
ALT
$580M
| $2.22M | ﹤0.01% |
189,600
| – | – |
|
|
TARO
1890
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.2M | ﹤0.01% |
60,790
| – | – |
|
1891
Insteel Industries
IIIN
$593M
| $2.15M | ﹤0.01% |
64,000
+700
| +1% | +$27.8K |
|
|
CELL
1892
DELISTED
PhenomeX Inc. Common Stock
CELL
| $2.14M | ﹤0.01% |
430,824
| – | – |
|
1893
Prothena Corp
PRTA
$440M
| $2.09M | ﹤0.01% |
76,800
| – | – |
|
1894
Cognyte Software
CGNT
$647M
| $2.08M | ﹤0.01% |
488,494
| – | – |
|
|
LX
1895
LexinFintech Holdings
LX
$246M
| $2.05M | ﹤0.01% |
917,563
| – | – |
|
|
AMRS
1896
DELISTED
Amyris Inc.
AMRS
| $2.04M | ﹤0.01% |
1,100,574
-50,672
| -4% | -$149K |
|
1897
Vroom Inc
VRM
$35.9M
| $2.02M | ﹤0.01% |
20,232
+19,455
| +2,504% | +$2.44M |
|
|
ECOM
1898
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2M | ﹤0.01% |
+137,500
| New | +$1.97M |
|
|
BTRS
1899
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $1.99M | ﹤0.01% |
+399,200
| New | +$2.3M |
|
1900
Banco Bilbao Vizcaya Argentaria
BBVA
$152B
| $1.94M | ﹤0.01% |
+430,000
| New | +$2.18M |
|
Similar funds
Norges Bank's Q2 2022 Portfolio in Review
As of Q2 2022, Norges Bank held 2,232 positions worth $387B, down 16% from $459B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Norges Bank's Q2 2022 filing shows 70 new, 787 increased, 1,058 reduced and 180 closed positions. Its largest new stake was Bausch + Lomb: 3,234,219 shares worth $49.3M. The largest sale was AT&T, an estimated $509M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Norges Bank's largest Q2 2022 buy was Bausch + Lomb: 3,234,219 shares worth $49.3M.
- Norges Bank added most to Microsoft in Q2 2022, an estimated $1.63B increase.
- Norges Bank's biggest Q2 2022 reduction was AT&T, cutting an estimated $509M.
- Norges Bank fully exited Cerner Corp in Q2 2022, selling an estimated $279M.
- Norges Bank's ten largest holdings make up 23% of its $387B portfolio in Q2 2022.
- Norges Bank opened 70 new positions and closed 180 in Q2 2022.
- Norges Bank's portfolio value fell 16% quarter-over-quarter to $387B.
Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.